References
Adeloye, D., Owolabi, E. O., Ojji, D. B., Auta, A., Dewan, M. T., Olanrewaju, T. O., Ogah, O. S., Omoyele, C., Ezeigwe, N., Mpazanje, R. G. & Gadanya, M. A. (2021). Prevalence, awareness, treatment and control of hypertension in Nigeria in 1995 and 2020: A systematic analysis of current evidence. The Journal of Clinical Hypertension, 23(5), 963–977. Adisa, R., Ilesanmi, O. A. & Fakeye, T. O. (2018). Treatment adherence and blood pressure outcome among hypertensive out-patients in two tertiary hospitals in Sokoto, Northwestern Nigeria. BMC Cardiovascular Disorders, 18(194), 1–12. Ajayi, I. O., Sowemimo, I. O., Akpa, O. M. & Ossai, N. (2016). Prevalence of hypertension and associated factors among residents of Ibadan-North Local Government Area of Nigeria. Nigerian Journal of Cardiology, 13(2), 67–75. Akonoghrere, R. O., Arute, J. E. & Akparobore, A. (2016). Impact of pharmaceutical care interventions on the quality of life of group of hypertensive patients. UK Journal of Pharmaceutical and Biosciences, 4(4), 19–28. Available at http://www.ukjpb.com Al Berek, P., Irawati, D. & Hamid, A. (2021). Hypertension: A global health crisis. Annals of Clinical Hypertension, 5, 8–11. Aranda-Jan, C. B., Mohutsiwa-Dibe, N. & Loukanova, S. (2014). Systematic review on what works, what does not work and why of implementation of mobile health (mHealth) projects in Africa. BMC Public Health, 14, 188. Auta, A., Strickland-Hodge, B., Maz, J. & David, S. (2017). Pharmacist prescribing: a cross- sectional survey of the views of pharmacists in Nigeria. International Journal of Pharmacy Practice, 26(2), 111–119. Ayogu, E. E., Yahaya, R. I., Isah, A. & Ubaka, C. M. (2023). Effectiveness of a pharmacist- led educational intervention on health outcomes in hypertension management at community pharmacies in Nigeria: A two-arm parallel single-blind randomized controlled trial. British Journal of Clinical Pharmacology, 89(2), 649–659. Bunting, B. A., Smith, B. H. & Sutherland, S. E. (2008). The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. Journal of the American Pharmacists Association, 48(1), 23–31. https://doi.org/10.1331/JAPhA.2008.07140 Burnier, M. & Egan, B. M. (2019). Adherence in hypertension. Circulation Research, 124(7), 1124–1140. https://doi.org/10.1161/CIRCRESAHA.118.313220 Chan, A. H. Y., Horne, R., Hankins, M. & Chisari, C. (2020). The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence. British Journal of Clinical Pharmacology, 86(7), 1281-1288. Cremers, A. L., Alege, A., Nelissen, H. E., Okwor, T. J., Osibogun, A., Gerrets, R., et al. (2018). Patients’ and healthcare providers’ perceptions and practices regarding hypertension, pharmacy-based care and mHealth in Lagos, Nigeria: A mixed methods study. Journal of Hypertension, 37(2):389-397. Erhun, W. O., Agbani, E. O. & Bolaji, E. E. (2005). Positive benefits of a pharmacist- managed hypertension clinic in Nigeria. Public Health, 119(10), 792–798. Etikan, I., Musa, S. A. & Alkassim, R. S. (2016). Comparison of convenience sampling and purposive Sampling. American Journal of Theoretical and Applied Statistics, 5(1), 1-4. Fadare, J. O., Enwere, O. O., Adeoti, A. O., Desalu, O. O. & Godman, B. (2020). Knowledge and attitude of physicians towards the cost of commonly prescribed medicines: A case study in three Nigerian healthcare facilities. Value in Health Regional Issues, 22, 68– Gastens, V., Kiszio, B., Del Giovane, C., Tsuyuki, R., Paradis, G., Chiolero, A. & Santschi, V. (2022). Pharmacist interventions to improve hypertension management: Protocol for a systematic review of randomised controlled trials. BMJ Open, 12(5), e059399. Hossain, A., Ahsan, G. U., Hossain, M. Z., Hossain, M. A., Sutradhar, P., Alam, S.-E., Sultana, Z. Z., Hijazi, H., Rahman, S. A., & Alameddine, M. (2025). Medication adherence and blood pressure control in treated hypertensive patients: First follow-up findings from the PREDIcT-HTN study in Northern Bangladesh. BMC Public Health, 25, 250. Ike, S. & Onyema, C. (2020). Cardiovascular diseases in Nigeria: What has happened in the past 20 years? Nigerian Journal of Cardiology, 17(1), 21–26. Iloh, G. U. P., Amadi, A. N., Okafor, G. O. C., Ikwudinma, A. O., Odu, F. U. & Godswill- Uko, E. O. (2014). Adherence to lifestyle modifications among adult hypertensive Nigerians with essential hypertension in a primary care clinic of a tertiary hospital in resource-poor environment of eastern Nigeria. British Journal of Medicine and Medical Research, 4(18), 3478–3490. James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., … Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. Karakurt, P. & Ka?ikçi, M. (2012). Factors affecting medication adherence in patients with hypertension. Journal of Vascular Nursing, 30(4), 118–126. Mahinrad, S., Sorond, F. A. & Gorelick, P. B. (2021). Hypertension and cognitive dysfunction: A review of mechanisms, life-course observational studies and clinical trial results. Reviews in Cardiovascular Medicine, 22(4), 1429–1449. Mezue, K. (2014). The increasing burden of hypertension in Nigeria - Can a dietary salt reduction strategy change the trend? Perspectives in Public Health, 134(6), 346–352. Mills, K. T., Obst, K. M., Shen, W., Molina, S., Zhang, H. J. & He, H. (2018). Comparative effectiveness of implementation strategies for blood pressure control in hypertensive patients: A systematic review and meta-analysis. Annals of Internal Medicine, 168, 110–120. Milosavljevic, A., Aspden, T. & Harrison, J. (2018). Community pharmacist-led interventions and their impact on patients' medication adherence and other health outcomes: A systematic review. International Journal of Pharmacy Practice, 26(5), 387–397. https://doi.org/10.1111/ijpp.12462 Morgado, M., Rolo, S. & Castelo-Branco, M. (2011). Pharmacist intervention program to enhance hypertension control: A randomised controlled trial. International Journal of Clinical Pharmacy, 33(1), 132–140. https://doi.org/10.1007/s11096-010-9474-x Nelissen, H. E., Cremers, A. L., Okwor, T. J., Kool, S., van Leth, F., Brewster, L., Makinde, O., Gerrets, R., Hendriks, M. E., Schultsz, C., Osibogun, A. & van’t Hoog, A. H. (2018). Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria: A mixed methods feasibility study. BMC Health Services Research, 18(1), 934. Odili, A. N., Chori, B. S., Danladi, B., Nwakile, P. C., Okoye, I. C., Abdullahi, U., … Isiguzo, G. C. (2020). Prevalence, awareness, treatment and control of hypertension in Nigeria: Data from a nationwide survey 2017. Global Heart, 15(1), 47. Oparah, A. C., Adje, D. U. & Enato, E. F. (2006). Outcomes of pharmaceutical care intervention to hypertensive patients in a Nigerian community pharmacy. International Journal of Pharmacy Practice, 14, 115–122. Santschi, V., Chiolero, A., Colosimo, A. L., Platt, R. W., Taffé, P., Burnier, M., et al. (2014). Improving blood pressure control through pharmacist interventions: A meta-analysis of randomized controlled trials. Journal of the American Heart Association, 10;3(2): e000718. Sorbor, G. F., Nep, E. I., Hallie, E. F., David, E. A., Smith, K. C., Peters, J. T. & Dapar, M. P. (2021). Impact of pharmacist clinical interventions on treatment outcomes in hypertensive patients: An outcomes study. International Journal of Innovative Science and Research Technology, 6(5), 681–688. http://www.ijisrt.com Spetz, K., Olbers, T., Östbring, M., Näslund, I., Sundbom, M. & Thorell, A. (2024). U
